EmpagroMet Sustained-release Tablet 25/1000 mg (Empagliflozin, Metformin)

Adult dose

The dosage of this medication is determined based on the treatment regimen, efficacy, and tolerability of the patient, without exceeding 25 mg of Empagliflozin and 2000 mg of sustained-release Metformin Hydrochloride per day. This medication is taken once daily in the evening with meals, and dosage increases should be made gradually. The 10/1000 mg or 25/1000 mg sustained-release tablets are taken once daily as a single tablet, and patients on the 5/1000

This medication can cause a rare side effect known as severe lactic acidosis, so if this symptom occurs, medical professionals should be informed immediately. There is a risk of hypoglycemia when used with other diabetes treatments, so caution is required. It should not be used in patients with poor kidney function or those with acute kidney issues. This medication is not indicated for patients with type 1 diabetes or certain metabolic acidosis conditions. It should be discontinued for a certain period prior to and after surgery, and can be resumed once kidney function is normalized. It is not recommended for women who are pregnant or could become pregnant. This medication may increase the risk of genital infections and urinary tract infections, so immediate treatment should be sought if infection symptoms appear. Vitamin B12 levels may decrease, so regular blood tests are recommended to monitor status. Patients at risk of fluid loss or dehydration should have blood pressure and fluid status monitored regularly. Alcohol consumption may increase the risk of side effects from this medication, so it should be avoided. This medication should not be crushed or chewed; it must be swallowed whole, and the tablet shell may appear in feces, which is normal. Elderly patients may have an increased risk of reduced kidney function, so kidney function testing is needed before starting treatment and should be monitored regularly. There may be interactions with other medications, so any concurrent medications should be disclosed to healthcare professionals. Blood sugar control should be monitored regularly while taking this medication, and medical consultation should occur if abnormal symptoms arise.

Serious side effects

• Urticaria
• angioedema
• necrotizing fasciitis
• ketoacidosis
• lactic acidosis
• urosepsis
• pyelonephritis
• acute renal injury
• acute pyelonephritis
• acute cholecystitis

Mild side effects

• Hypoglycemia
• urinary tract infections
• genital infections
• increased urination
• nausea
• vomiting
• diarrhea
• abdominal pain
• loss of appetite
• constipation

This medication must be stored in a tightly sealed container to protect it from air and moisture. It should also be kept at room temperature, between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance

Light yellow, biconvex, oval-shaped sustained-release film-coated tablet

Package unit

30 tablets / bottle